Circassia Pharmaceuticals (LON:CIR)

Circassia Pharmaceuticals (LON:CIR)


Share Price
18.65 p
Change
0 (0.00 %)
Market Cap
£69.96 m
Proactive Investors - Run By Investors For Investors

Circassia Pharmaceuticals RNS Release

Total Voting Rights


RNS Number : 5975A
Circassia Pharmaceuticals Plc
31 May 2019
 

For immediate release

 

Circassia Pharmaceuticals plc

 

Total Voting Rights Update

 

 

 

31st May 2019

 

In accordance with the requirements of the FCA's Disclosure and Transparency Rule 5.6.1, Circassia Pharmaceuticals plc ("Circassia" or "the Company") (LSE: CIR) confirms that the Company's issued share capital consists of 375,048,054 ordinary shares of 0.08p each in issue, each with equal voting rights.  No shares are held in treasury.

 

The above figure may be used by shareholders as the denominator for the calculations by which they will determine whether they are required to notify their interest, or a change to their interest, in the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

-Ends-

 

For further information, please contact:

 

Circassia Pharmaceuticals plc

Julien Cotta, Company Secretary

 

+44 (0) 1865 405560

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
TVREAPSEDFKNEEF

Circassia Pharmaceuticals Timeline

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use